Spyre Therapeutics, Inc. (SYRE) stock
SYRENasdaqPharmaceutical PreparationsFiscal year ends December 31
$97.63−3.83 (-3.77%)
Close on Nov 19, 2026Market cap $8.61BP/E –Yield –
Spyre Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Spyre Therapeutics's market cap was $9.41B on Nov 11, 2026, against $1.81B a year earlier. Over the last 5 years it ranged from $8.49M to $9.41B, with a median of $972.25M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $9.41B | +374.8% |
| 2025 | Dec 31, 2025 | $1.98B | +65.6% |
| 2024 | Dec 31, 2024 | $1.20B | +1273.3% |
| 2023 | Dec 29, 2023 | $87.13M | +214.8% |
| 2022 | Dec 30, 2022 | $27.67M | -88.2% |
| 2021 | Dec 31, 2021 | $234.20M | -33.4% |
| 2020 | Dec 31, 2020 | $351.73M | +59.2% |
| 2019 | Dec 31, 2019 | $220.97M | +33.5% |
| 2018 | Dec 31, 2018 | $165.52M | +85.7% |
| 2017 | Dec 29, 2017 | $89.12M | +52.5% |
| 2016 | Dec 30, 2016 | $58.42M | – |
See a number that looks wrong?